Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed,
and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government
operating status and resumption of normal operations can be found at opm.gov.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01739283
: December 3, 2012
Last Update Posted
: July 13, 2015
University of Copenhagen
Information provided by (Responsible Party):
Mikkel Christensen, University Hospital, Gentofte, Copenhagen
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 50 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
• Diagnosed with type 1 diabetes (WHO criteria)
HbA1c > 9 %
Liver disease (ALAT/ASAT > 2 x upper normal limit)
Diabetic nephropathy (s-creatinine > 130 µM or albuminuria)
Proliferative diabetic retinopathy (anamnestic)
Severe arteriosclerosis or heart failure (NYHA group III or IV)
treatment with medication not applicable to pause for 12 hours